mci 9038 has been researched along with Ventricular Dysfunction, Left in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Böhm, M; Link, A; Pöss, J | 1 |
Haeberle, L; Nohe, B; Ploppa, A; Schmid, E | 1 |
Gordan, L; Gorman, R; Kitchens, C; Zumberg, M | 1 |
3 other study(ies) available for mci 9038 and Ventricular Dysfunction, Left
Article | Year |
---|---|
[Diagnosis and treatment of heparin-induced thrombocytopenia].
Topics: Acute Kidney Injury; Aged; Anticoagulants; Antithrombins; Aortic Valve Stenosis; Arginine; Diagnosis, Differential; Hand; Heparin; Humans; Ischemia; Male; Pipecolic Acids; Platelet Count; Renal Dialysis; Shock, Cardiogenic; Sulfonamides; Thrombocytopenia; Ventricular Dysfunction, Left | 2011 |
Left ventricular thrombus during cardiopulmonary bypass as the primary manifestation of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Cardiopulmonary Bypass; Echocardiography, Transesophageal; Heparin; Humans; Intraoperative Complications; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Sulfonamides; Thrombocytopenia; Thromboembolism; Ventricular Dysfunction, Left | 2013 |
Successful use of argatroban as an anticoagulant in burn-related severe acquired antithrombin III deficiency after heparin failure.
Topics: Accidents, Home; Adult; Anticoagulants; Antithrombin III Deficiency; Arginine; Burns; Cardiovascular Agents; Coronary Vasospasm; Debridement; Drug Therapy, Combination; Explosions; Humans; Male; Pipecolic Acids; Sulfonamides; Ventricular Dysfunction, Left; Warfarin | 2001 |